Related Experiment Video
Updated: Jul 14, 2026
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness
A Barceló1, M de la Peña, F Barbé
1Servei de Analisis Cliniques and Pneumologia, C/Andrea Doria 55, 07014 Palma de Mallorca, Spain. abarcelo@hsd.es
Background:
Excessive daytime sleepiness (EDS) occurs often in patients with obstructive sleep apnea syndrome (OSAS). However, not all patients present EDS. We hypothesized that the prostaglandin D2 system (PGD2) may be involved in the pathogenesis of EDS associated with OSAS.
Methods:
We measured the levels of lipocalin-type PGD synthase (L-PGDS), the enzyme that produces PGD2, in the serum of 47 patients with OSAS (26 with and 21 without EDS) and 18 healthy controls.
Results:
Patients with EDS had higher levels of L-PGDS (0.73+/-0.06 mg/L) than patients without EDS (0.58+/-0.03 mg/L, p<0.05) and controls (0.62+/-0.02 mg/L, p<0.05). L-PGDS levels in patients without EDS and controls were similar.
Conclusion:
The increased levels of circulating L-PGDS detected in OSAS patients with EDS suggest a possible role of the prostaglandin D system in the pathophysiology of daytime sleepiness in these patients.
